Tang Capital Management »

GSK shares owned by Tang Capital Management

Quarter-by-quarter ownership of GSK (GSK) shares owned by Tang Capital Management from 13F filings

Historical chart of Tang Capital Management investment in GSK

Tip: Access up to 7 years of quarterly data

All positions including GSK held by Tang Capital Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in GSK by Tang Capital Management

Quarter filed Position value Share count Share price at filing
2023-12-31 $11M 300k 37.06

More positions owned by Tang Capital Management

Mirati Therapeutics
ImmunoGen
Tarsus Pharmaceuticals (TARS)
Kalvista Pharmaceuticals (KALV)
Lianbio Sponsored Ads (LIANY)
Anaptysbio Inc Common (ANAB)
Mirum Pharmaceuticals (MIRM)
Evolus (EOLS)
Altimmune Com New (ALT)
Immunocore Hldgs Ads (IMCR)
Axsome Therapeutics (AXSM)
Ptc Therapeutics I (PTCT)
Gracell Biotechnologies Sponsored Ads
Revolution Medicines (RVMD)
Vaxcyte (PCVX)

View all positions for Tang Capital Management

Top funds holding GSK

Dodge & Cox
JTC Employer Solutions Trustee
Fisher Investments
T. Rowe Price Associates
PRIMECAP Management Company
Royal Bank of Canada
Holocene Advisors
Goldman Sachs Group
Arrowstreet Capital, Limited Partnership
Provident Trust
Equity Investment Corp Acquisition
Hotchkis and Wiley Capital Management
Wells Fargo & Company
Hsbc Holdings
Douglas Lane & Associates

View all funds holding GSK